rs80338963
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Transcriptional control by the TGF-beta/Smad signaling system.
|
10775259 |
2000 |
rs80338963
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads.
|
9679244 |
1998 |
rs80338963
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.
|
10479724 |
1999 |
rs80338963
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Somatic alterations of the DPC4 gene in human colorectal cancers in vivo.
|
8898652 |
1996 |
rs80338963
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.
|
10479724 |
1999 |
rs80338963
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.
|
17994767 |
2007 |
rs80338963
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads.
|
9679244 |
1998 |
rs80338963
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Role of Smad4 (DPC4) inactivation in human cancer.
|
12821112 |
2003 |
rs80338963
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.
|
17994767 |
2007 |
rs80338963
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
|
14715079 |
2004 |
rs80338963
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Role of Smad4 (DPC4) inactivation in human cancer.
|
12821112 |
2003 |
rs80338963
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Somatic alterations of the DPC4 gene in human colorectal cancers in vivo.
|
8898652 |
1996 |
rs80338963
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
|
14715079 |
2004 |
rs80338963
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs770248150
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.
|
16618717 |
2006 |
rs770248150
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.
|
19114683 |
2009 |
rs770248150
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
|
18316791 |
2008 |
rs770248150
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.
|
20921465 |
2010 |
rs770248150
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.
|
19679400 |
2009 |
rs770248150
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.
|
20921465 |
2010 |
rs770248150
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.
|
19679400 |
2009 |
rs770248150
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma.
|
16361624 |
2005 |
rs770248150
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma.
|
16361624 |
2005 |
rs770248150
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.
|
21228335 |
2011 |
rs770248150
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
|
20921462 |
2010 |